Influence
August 24, 2021

Regenstrief research scientist contributes to new national stroke treatment guideline

Regenstrief research scientist contributes to new national stroke treatment guideline

A Regenstrief Institute research scientist has helped author new national guidelines to reduce the risk of a second stroke.

Neurologist Linda Williams, M.D., is a member of the American Heart Association writing group for the updated guideline titled “2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack.”  In addition to her role at Regenstrief, Dr. Williams is affiliated with the U.S. Department of Veterans Affairs and Indiana University School of Medicine.

The new guideline encourages providers to tailor stroke prevention strategies based on the cause of the stroke.

Dr. Williams is an experienced neurologist who has conducted extensive research on stroke and TIA care. In this report, she authored the sections on homocysteine, embolic stroke of undetermined source and the use of antithrombotic medications.

As a writing group member, Dr. Williams reviewed all sections of the guidelines. This update is the first since 2014.

About Linda Williams, M.D.

In addition to her role as a research scientist at Regenstrief, Linda S. Williams, M.D., is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. She also is a professor of neurology at Indiana University School of Medicine.

Related News

April Savoy, PhD

Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing

illustration of digestive tract with magnifier and stool sample container

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale explains why physicians should be good stewards of colonoscopy resources.  [button_links href=”https://www.regenstrief.org/article/regenstrief-researcher-calls-for-tailoring-colorectal-cancer-screening-45-49-year-olds/” title=”Read the full

Drs. David Haggstrom and Eric Vachon: Personal Health Records for Cancer Survivors

Drs. David Haggstrom and Eric Vachon: Personal Health Records for Cancer Survivors

Dr. David Haggstrom, MD, MAS, and Dr. Eric Vachon, PhD, RN, discuss their feasibility study that showed implementing a